In the last trading session, 19.39 million shares of the Pliant Therapeutics Inc (NASDAQ:PLRX) were traded, and its beta was 1.19. Most recently the company’s share price was $1.38, and it changed around -$2.06 or -59.88% from the last close, which brings the market valuation of the company to $83.98M. PLRX currently trades at a discount to its 52-week high of $17.58, offering almost -1173.91% off that amount. The share price’s 52-week low was $2.43, which indicates that the current value has fallen by an impressive -76.09% since then.
Pliant Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.33. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 9 recommended PLRX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Pliant Therapeutics Inc is expected to report earnings per share of -0.89 for the current quarter.
Pliant Therapeutics Inc (NASDAQ:PLRX) trade information
Instantly PLRX has showed a red trend with a performance of -59.88% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.46 on recent trading dayincreased the stock’s daily price by 60.12%. The company’s shares are currently down -89.52% year-to-date, but still down -54.46% over the last five days. On the other hand, Pliant Therapeutics Inc (NASDAQ:PLRX) is -87.05% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $35.5, which translates to bulls needing to increase their stock price by 96.11% from its current value. Analyst projections state that PLRX is forecast to be at a low of $33 and a high of $38.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -22.68%. Pliant Therapeutics Inc earnings are expected to increase by -5.86% in 2025, but the outlook is positive 5.20% per year for the next five years.
PLRX Dividends
Pliant Therapeutics Inc’s next quarterly earnings report is expected to be released in April.
BLACKROCK INC., with 8.2612% or 4.97 million shares worth $53.45 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.34 shares worth $3.23 million, making up 3.84% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 2.03 shares worth around $2.8 million, which represents about 3.34% of the total shares outstanding.
